SynthesisMedicine2025

Effectiveness of regorafenib in second-line therapy for advanced hepatocellular carcinoma: A systematic review and meta-analysis.

Yunzhi Shen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.